- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/76 - Albumins
Patent holdings for IPC class C07K 14/76
Total number of patents in this class: 406
10-year publication summary
|
45
|
23
|
45
|
35
|
37
|
48
|
31
|
24
|
33
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| EpiVax, Inc. | 80 |
16 |
| Perfect Day, Inc. | 56 |
12 |
| Bioverativ Therapeutics Inc. | 215 |
11 |
| Neutrolis, Inc. | 32 |
11 |
| Zymeworks Inc. | 256 |
8 |
| Sanofi Aatd Inc. | 14 |
7 |
| CSL Behring GmbH | 344 |
6 |
| Sartorius Albumedix Limited | 46 |
6 |
| Ablynx N.V. | 395 |
5 |
| Hamlet Pharma AB | 18 |
5 |
| Medicenna Therapeutics Inc. | 38 |
5 |
| Centre National de La Recherche Scientifique | 10414 |
4 |
| Massachusetts Institute of Technology | 10036 |
4 |
| Mayo Foundation for Medical Education and Research | 3201 |
4 |
| The Brigham and Women's Hospital, Inc. | 2179 |
4 |
| Georgia State University Research Foundation, Inc. | 344 |
4 |
| Jubilant DraxImage Inc. | 143 |
4 |
| Regents of the University of Minnesota | 2688 |
4 |
| Keros Therapeutics, Inc. | 64 |
4 |
| Invitria, Inc. | 41 |
4 |
| Other owners | 278 |